Antimicrobial soap continuum model could benefit from consumer feedback -- FDA.
This article was originally published in The Rose Sheet
Executive Summary
ANTIMICROBIAL SOAP HEALTH CARE CONTINUUM: CONSUMER FEEDBACK SUGGESTED BY FDA Office of Drug Evaluation V Director Michael Weintraub, MD, at a March 10 "feedback" meeting with FDA, the Cosmetic, Toiletry and Fragrance Association and the Soap and Detergent Association on industry's proposed category of use model for antimicrobial soap products. As the "end users" of antimicrobial products, consumers may have "critiques and constructive suggestions that would be...very valuable" in fine-tuning the continuum, Weintraub said.